Aridis Pharmaceuticals Inc (NASDAQ:ARDS)

1.13
Delayed Data
As of Jul 06
 +0.02 / +1.82%
Today’s Change
0.88
Today|||52-Week Range
7.69
-51.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues2.9M2.3M860.0K2.8M
 
 
 
 
 
Cost of Goods Sold2.1M1.9M0.00--
 
 
 
Depreciation And Amortization27.0K23.0K62.0K281.0K
 
 
 
 
 
 
Operating ExpensesGross Income714.0K342.0K798.0K--
 
 
 
 
General Expenses8.6M8.2M20.5M26.6M
 
 
 
 
 
Research And Development5.3M6.3M17.4M23.0M
 
 
 
 
 
Total Operating Expenses10.8M10.2M20.6M26.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.9M-7.9M-19.7M-24.1M
 
 
 
 
 
Extraordinary Credit0.000.000.001.6M
 
 
Extraordinary Charge0.00-172.0K-5.2M0.00
 
 
 
Pre-Tax Equity Earnings0.000.000.00-40.0K
 
 
Interest Expense On Debt296.0K366.0K--0.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.2M-8.4M-24.7M-22.1M
 
 
 
 
 
Preferred Dividend0.00-465.0K-2.8M-1.4M
 
 
 
 
Net Income-8.2M-8.4M-24.7M-22.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS8.2M8.2M8.2M3.1M
 
 
 
 
 
Shares To Calculate EPS Diluted8.2M8.2M8.2M3.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.00-$1.09-$3.35-$7.45
 
 
 
 
 
EPS Diluted-$1.00-$1.09-$3.35-$7.46